Use of sotalol in the prevention of atrial fibrillation in patients after coronary artery bypass grafting;Stosowanie sotalolu w zapobieganiu migotaniu przedsionków po zabiegach pomostowania aortalno-wieńcowego

Folia Cardiologica

Volumn 12, Issue 2, 2005, Pages 77-83

  Zwoliński, Radosław ^a   Banach, Maciej ^a   Golański, Ryszard ^a   Markuszewski, Leszek ^a   Iwaszkiewicz Zasłonka, Alicja ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Antiarrhythmic drugs; Atrial fibrillation; Sotalol

Indexed keywords

ANTIARRHYTHMIC AGENT; METOPROLOL; PLACEBO; SOTALOL;

CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DATA ANALYSIS; EDITORIAL; HEALTH CARE COST; HEALTH STATUS; HEART ATRIUM FIBRILLATION; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HOSPITALIZATION; HUMAN; MEDICAL RESEARCH; MORBIDITY; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PREOPERATIVE PERIOD; PUBLISHING; SIDE EFFECT;

EID: 15844430622     PISSN: 15074145     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (23)

1. Opolski G., Torbicki A. red. Migotanie przedsionków. Praca zbiorowa. Wyd. II. Urban & Partner, Wrocław 2000: 165.
2. Crijns H.J.G.M., Van Den Berg M.P., Van Gelder I.C. i wsp. Management of atrial fibrillation in the setting of heart failure. Eur. Heart J. 1997; 18: C45-C49.
3. Banach M., Okońiski P., Gruda J. Aktualne wytyczne postepowania w migotaniu przedsionków u chorych poddawanych operacji rewaskularyzacji. Forum Kardiologów 2004; 9: 51-54.
4. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur. Heart J. 2001; 22: 1852-1923.
5. The Amiodarone Reduction in Coronary Heart (ARCH) Trial Investigators. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery. J. Am. Coll. Cardiol. 1999; 34: 343-347.
6. Butler J., Harriss D.R., Sinclair M. i wsp. Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomized, double-blind, placebo-controlled trial. Br. Heart J. 1993; 70: 56-60.
7. Harahsheh B.S., Sawalha W.A. Effect of amiodarone on atrial fibrillation after coronary artery bypass surgery. Saudi. Med. J. 2001; 22: 797-799.
8. Cioffi G., Cemin C., Russo T.E. i wsp. Post-discharge recurrences of new-onset atrial fibrillation followed cardiac surgery: impact of low-dose amiodarone and β-blockers prophylaxis. Ital. Heart J. 2000; 1: 691-697.
9. Roy N., O'Hara G.E., Talajic M. i wsp. Improved efficacy of iv propafenone compared to iv procainamide for conversion of atrial fibrillation after cardiac surgery. Circulation 1994; 90: I-542. (streszczenie)
10. The lbutilide For Atrial Fibrillation/Flutter Termination after cardiac surgery trail investigators. Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery. N. Engl. J. Med. 1999; 100: 369-375.
11. Yagdi T., Nalbantgil S., Ayik F. i wsp. Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg. 2003; 125: 1420-1425.
12. Siebert J., Lewicki Ł., Młodnicki M. i wsp. Atrial fibrillation after conventional and off-pump coronary artery bypass grafting: two opposite trends in timing of atrial fibrillation occurrence? Med. Sci. Monit. 2003; 9: CR137-CR141.
13. Campbell T.J., Gavaghan T.P., Mogan J.J. Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass. Comparison with disopyramide and digoxin in randomized trial. Br. Heart J. 1985; 2: 86-90.
14. Parikka H, Toivonen L, Heikkilä L i wsp. Comparison of sotalol and metoprolol in the prevention of atrial fibrillation after coronary artery bypass surgery. J. Cardiovasc. Pharmacol. 1998; 31: 67-73.
15. Wurdeman R.L., Mooss A.N., Mohiuddin S.M., Lenz T.L. Amiodarone vs. sotalol as prophylaxis against atrial fibrillation/flutter after heart surgery: a meta-analysis. Chest 2002; 121: 1203-1210.
16. Morady F. Prevention of atrial fibrillation in the postoperative cardiac patient: significance of oral class III antiarrhythmic agents. Am. J. Cardiol. 1999; 84: 156R-160R.
17. Nystrom U., Edvardsson N., Berggren H. i wsp. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery. Thorac. Cardiovasc. Surg. 1993; 41: 34-37.
18. Weber U.K., Osswald S., Huber M. i wsp. Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: is there a need for pre-operative risk stratification? A prospective placebo-controlled study using low-dose sotalol. Eur. Heart J. 1998; 19: 794-800.
19. Matsuura K., Takahara Y., Sudo Y., Ishida K. Effect of sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. Jpn. J. Thorac. Cardiovasc. Surg. 2001; 49: 614-617.
20. Pfisterer M.E., Klöter-Weber U.C., Huber M. i wsp. Prevention of supraventricular tachyarrhythmias after open heart operation by low-dose sotalol: a prospective, double-blind, randomized, placebo-controlled study. Ann. Thorac. Surg. 1997; 64: 1113-1119.
21. Gomes J.A., Ip J., Santoni-Rugiu F. i wsp. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study. J. Am. Coll. Cardiol. 1999; 34: 334-339.
22. Forlani S., De Paulis R., de Notaris S. i wsp. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Ann. Thorac. Surg. 2002; 74: 720-725.
23. Forlani S., Moscarelli M., Scafuri A. Combination therapy for prevention of atrial fibrillation after coronary artery bypass surgery: a randomized trial of sotalol and magnesium. Card. Electrophysiol. Rev. 2003; 7: 168-171.